Klus GT - Search Results

1

Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts.

Póti Á, Berta K, Xiao Y, Pipek O, Klus GT, Ried T, Csabai I, Wilcoxen K, Mikule K, Szallasi Z, Szüts D. Póti Á, et al. Among authors: klus gt. Br J Cancer. 2018 Nov;119(11):1392-1400. doi: 10.1038/s41416-018-0312-6. Epub 2018 Nov 14. Br J Cancer. 2018. PMID: 30425352 Free PMC article.

2

Simultaneous suppression of epidermal growth factor receptor and c-erbB-2 reverses aneuploidy and malignant phenotype of a human ovarian carcinoma cell line.

Pack SD, Alper OM, Stromberg K, Augustus M, Ozdemirli M, Miermont AM, Klus G, Rusin M, Slack R, Hacker NF, Ried T, Szallasi Z, Alper O. Pack SD, et al. Cancer Res. 2004 Feb 1;64(3):789-94. doi: 10.1158/0008-5472.can-03-1982. Cancer Res. 2004. PMID: 14871800

3

Mutual information analysis as a tool to assess the role of aneuploidy in the generation of cancer-associated differential gene expression patterns.

Klus GT, Song A, Schick A, Wahde M, Szallasi Z. Klus GT, et al. Pac Symp Biocomput. 2001:42-51. doi: 10.1142/9789814447362_0005. Pac Symp Biocomput. 2001. PMID: 11262960 Free article.

4

Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer.

Klus GT, Rokaeus N, Bittner ML, Chen Y, Korz DM, Sukumar S, Schick A, Szallasi Z. Klus GT, et al. Int J Oncol. 2001 Jul;19(1):169-74. doi: 10.3892/ijo.19.1.169. Int J Oncol. 2001. PMID: 11408939

5

Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements.

Mecham BH, Klus GT, Strovel J, Augustus M, Byrne D, Bozso P, Wetmore DZ, Mariani TJ, Kohane IS, Szallasi Z. Mecham BH, et al. Among authors: klus gt. Nucleic Acids Res. 2004 May 25;32(9):e74. doi: 10.1093/nar/gnh071. Nucleic Acids Res. 2004. PMID: 15161944 Free PMC article.

6

Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness.

Wangsa D, Quintanilla I, Torabi K, Vila-Casadesús M, Ercilla A, Klus G, Yuce Z, Galofré C, Cuatrecasas M, Lozano JJ, Agell N, Cimini D, Castells A, Ried T, Camps J. Wangsa D, et al. FASEB J. 2018 Jul;32(7):3502-3517. doi: 10.1096/fj.201700247RR. Epub 2018 Feb 8. FASEB J. 2018. PMID: 29452566 Free PMC article.

7

Assessing the significance of consistently mis-regulated genes in cancer associated gene expression matrices.

Wahde M, Klus GT, Bittner ML, Chen Y, Szallasi Z. Wahde M, et al. Among authors: klus gt. Bioinformatics. 2002 Mar;18(3):389-94. doi: 10.1093/bioinformatics/18.3.389. Bioinformatics. 2002. PMID: 11934737

8

Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.

Klus GT, Nakamura J, Li JS, Ling YZ, Son C, Kemppainen JA, Wilson EM, Brodie AM. Klus GT, et al. Cancer Res. 1996 Nov 1;56(21):4956-64. Cancer Res. 1996. PMID: 8895750

9

Synthesis of novel 21-trifluoropregnane steroids: inhibitors of 17 alpha-hydroxylase/17,20-lyase (17 alpha-lyase).

Njar VC, Klus GT, Johnson HH, Brodie AM. Njar VC, et al. Among authors: klus gt. Steroids. 1997 Jun;62(6):468-73. doi: 10.1016/s0039-128x(97)00016-0. Steroids. 1997. PMID: 9185294

10

17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P450(17 alpha).

Ling YZ, Li JS, Liu Y, Kato K, Klus GT, Brodie A. Ling YZ, et al. Among authors: klus gt. J Med Chem. 1997 Sep 26;40(20):3297-304. doi: 10.1021/jm970337k. J Med Chem. 1997. PMID: 9379450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters